KYORIN Holdings, Inc. [4569.T]

KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex, an allergic rhinitis therapeutic agent; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug...

Stats
Current Price	JPY1 708.00
Today's Volume	25 100T
Average Volume	69 788T
Market Cap	97.87B
EPS	88.19
P/E	19.37
ATR14	JPY0.903 (0.05%)